Susan Rhodes
AbbVie (United States)(US)
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, Myeloproliferative Neoplasms: Diagnosis and Treatment, Glycosylation and Glycoproteins Research, Chronic Myeloid Leukemia Treatments, Viral Infectious Diseases and Gene Expression in Insects
Most-Cited Works
- → Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene(1998)757 cited
- → CS1, a Potential New Therapeutic Antibody Target for the Treatment of Multiple Myeloma(2008)560 cited
- → The Extent of Linkage Disequilibrium in Four Populations with Distinct Demographic Histories(2000)182 cited
- → JAK2/STAT5 inhibition by nilotinib with ruxolitinib contributes to the elimination of CML CD34+ cells in vitro and in vivo(2014)154 cited
- → Real-world experience with caplacizumab in the management of acute TTP(2020)153 cited
- → An anti-PD-1–GITR-L bispecific agonist induces GITR clustering-mediated T cell activation for cancer immunotherapy(2022)66 cited
- → Volociximab, a chimeric integrin alpha5beta1 antibody, inhibits the growth of VX2 tumors in rabbits(2007)62 cited
- → Use of the Glu-Glu-Phe C-terminal epitope for rapid purification of the catalytic domain of normal and mutant ras GTPase-activating proteins(1991)56 cited
- → Expression and characterization of the Ha-ras p21 protein produced at high levels in the insect/baculovirus system(1989)48 cited
- → Characterization of recombinant human Kirsten-ras (4B) p21 produced at high levels in Escherichia coli and insect baculovirus expression systems(1991)36 cited